Inventor

RUOSLAHTI ERKKI I

US44 patents

⚠️ This page may combine multiple inventors who share the name “RUOSLAHTI ERKKI I”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

RUOSLAHTI ERKKI I

JOLLA CANCER RES FOUND

Vitronectin specific cell receptor derived from mammalian mesenchymal tissue

Polypeptide

Polypeptide

Polypeptide

β3 integrin cytoplasmic domain specific peptide and nucleic acid

Isolation and use of receptors binding to a peptide column

Peptides in cell detachment and aggregation

Conformationally stabilized cell adhesion peptides

Isolation and use fibronectin receptor

Tetrapeptide

Use of fibromodulin to prevent or reduce dermal scarring

Peptides of the cytoplasmic domain of integrin

Suppression of cell proliferation by decorin

Treatment of glomerulonephritis with decorin

Decorin fragments inhibiting cell regulatory factors

Inhibition of transforming growth factor beta activity

Fibronectin Type III polypeptides

Method of modulating tumor cell migration using fibronectin type III peptides

Fibronectin receptor

Cooperative combinations of ligands contained within a matrix

Polypeptide-polymer conjugates active in wound healing

Methods of modulating fibronectin extracellular matrix assembly

Integrin-binding peptides

Conformationally stabilized cell adhesion peptides

Conformationally stabilized cell adhesion peptides

Conformationally stabilized cell adhesion peptides

Inhibition of cell migration with synthetic peptides

Versican core protein, nucleic acid sequences encoding the same, nucleic acid probes, anti-versican antibodies, and methods of detecting the same

Adhesion receptor for laminin and its use

Polypeptide fragments of fibronectin which can modulate extracellular matrix assembly

Method for detection of fibronectin receptor ligands

Method for the purification of collagens

Methods of treating a pathology or a fibrotic condition by administering decorin

Conformationally stabilized cell adhesion peptides

Conformationally stabilized cell adhesion peptides

Selection of cells having increased cell adhesion properties

Methods of decreasing the accumulation of extracellular matrix associated with glomerulonephritis with anti-TGF-β-specific antibodies

BURNHAM INST

Conformationally stabilized cell adhesion peptides

Methods of preventing or reducing scarring with decorin or biglycan

Methods for inhibiting TGF-β activity

JOLLA CANCER RESEARCH CENTER

Cooperative combinations of ligands contained within a matrix

JOLLA CANCER RES INST

Conformationally stabilized cell adhesion peptides

LAAKKONEN PIRJO

Peptides that home to tumor lymphatic vasculature and methods of using same

LAJOLLA CANCER RESEARCH FOUNDA

Selection of cells having increased cell adhesion properties